Treatment with a novel hexavalent OX40 agonist remodels the tumor microenvironment to favor anti-tumor immunity in mice
Document Type
Abstract
Publication Date
11-1-2023
Keywords
oregon; chiles
Clinical Institute
Cancer
Department
Oncology
Recommended Citation
Kasiewicz, M; Redmond, Will; and See full list of authors in comments, "Treatment with a novel hexavalent OX40 agonist remodels the tumor microenvironment to favor anti-tumor immunity in mice" (2023). Articles, Abstracts, and Reports. 8371.
https://digitalcommons.providence.org/publications/8371
COinS
Comments
Kasiewicz M, Rolig A, Yadav R, Durana YDD, Redmond WL. SITC Annual Meeting; November 1-5; San Diego, CA. 2023;11(Suppl 1): 1360.